APO Research
Talk to an analyst

APO RESEARCH · REPORT

Critical Care Adsorption Solutions

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Critical Care Adsorption Solutions Market Outlook and Growth Opportunities 2026

12 August 2026196 pages

Choose your research edition.

Industry ResearchCritical Care Adsorption Solutions Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Critical Care Adsorption Solutions Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal Critical Care Adsorption Solutions Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Critical Care Adsorption Solutions Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Critical Care Adsorption Solutions Market Analysis and Forecast 2026-2032174 pages · $4,950 USD

Market perspective

The global Critical Care Adsorption Solutions market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Critical Care Adsorption Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Critical Care Adsorption Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Critical Care Adsorption Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Critical Care Adsorption Solutions market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Critical Care Adsorption Solutions market include Aier, Biosun Corporation, Baxter, Jafron Biomedical, Guangzhou Kangsheng Biotechnology, Baihe Medical, Asahi Kasei Corporation, Toray Medical and Kaneka Medix Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Critical Care Adsorption Solutions market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Critical Care Adsorption Solutions and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Critical Care Adsorption Solutions revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Critical Care Adsorption Solutions market.

Critical Care Adsorption Solutions Segment by Company

Aier

Biosun Corporation

Baxter

Jafron Biomedical

Guangzhou Kangsheng Biotechnology

Baihe Medical

Asahi Kasei Corporation

Toray Medical

Kaneka Medix Corporation

Critical Care Adsorption Solutions Segment by Type

Immunoadsorption

Lipid Adsorption

Others

Critical Care Adsorption Solutions Segment by Application

Cardiac Surgery Department

Sepsis

Burn

Pancreatitis

Others

Critical Care Adsorption Solutions Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Critical Care Adsorption Solutions status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Critical Care Adsorption Solutions key companies, revenue, market share, and recent developments.

3. To split the Critical Care Adsorption Solutions breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Critical Care Adsorption Solutions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Critical Care Adsorption Solutions significant trends, drivers, influence factors in global and regions.

6. To analyze Critical Care Adsorption Solutions competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Critical Care Adsorption Solutions market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Critical Care Adsorption Solutions and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Critical Care Adsorption Solutions.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Critical Care Adsorption Solutions industry.

Chapter 3: Detailed analysis of Critical Care Adsorption Solutions company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Critical Care Adsorption Solutions in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Critical Care Adsorption Solutions in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Critical Care Adsorption Solutions Industry Trends Table 2. Critical Care Adsorption Solutions Industry Drivers Table 3. Critical Care Adsorption Solutions Industry Opportunities and Challenges Table 4. Critical Care Adsorption Solutions Industry Restraints Table 5. Global Critical Care Adsorption Solutions Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Critical Care Adsorption Solutions Revenue Share by Company (2021-2026) Table 7. Global Critical Care Adsorption Solutions Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Critical Care Adsorption Solutions Key Company Manufacturing Base & Headquarters Table 9. Global Critical Care Adsorption Solutions Company, Product Type & Application Table 10. Global Critical Care Adsorption Solutions Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Critical Care Adsorption Solutions by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Immunoadsorption Table 15. Significant Companies of Lipid Adsorption Table 16. Significant Companies of Others Table 17. Global Critical Care Adsorption Solutions Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Critical Care Adsorption Solutions Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Critical Care Adsorption Solutions Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Critical Care Adsorption Solutions Sales Value Share by Type (2021-2026) Table 21. Global Critical Care Adsorption Solutions Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Cardiac Surgery Department Table 23. Significant Companies of Sepsis Table 24. Significant Companies of Burn Table 25. Significant Companies of Pancreatitis Table 26. Significant Companies of Others Table 27. Global Critical Care Adsorption Solutions Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Critical Care Adsorption Solutions Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Critical Care Adsorption Solutions Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Critical Care Adsorption Solutions Sales Value Share by Application (2021-2026) Table 31. Global Critical Care Adsorption Solutions Sales Value Share by Application (2027-2032) Table 32. Global Critical Care Adsorption Solutions Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Critical Care Adsorption Solutions Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Critical Care Adsorption Solutions Sales Value Share by Region (2021-2026) Table 35. Global Critical Care Adsorption Solutions Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Critical Care Adsorption Solutions Sales Value Share by Region (2027-2032) Table 37. Global Critical Care Adsorption Solutions Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Critical Care Adsorption Solutions Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Critical Care Adsorption Solutions Sales Value Market Share by Country (2021-2026) Table 40. Global Critical Care Adsorption Solutions Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Critical Care Adsorption Solutions Sales Value Market Share by Country (2027-2032) Table 42. Aier Company Information Table 43. Aier Business Overview Table 44. Aier Critical Care Adsorption Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Aier Critical Care Adsorption Solutions Product Portfolio Table 46. Aier Recent Development Table 47. Biosun Corporation Company Information Table 48. Biosun Corporation Business Overview Table 49. Biosun Corporation Critical Care Adsorption Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Biosun Corporation Critical Care Adsorption Solutions Product Portfolio Table 51. Biosun Corporation Recent Development Table 52. Baxter Company Information Table 53. Baxter Business Overview Table 54. Baxter Critical Care Adsorption Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Baxter Critical Care Adsorption Solutions Product Portfolio Table 56. Baxter Recent Development Table 57. Jafron Biomedical Company Information Table 58. Jafron Biomedical Business Overview Table 59. Jafron Biomedical Critical Care Adsorption Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Jafron Biomedical Critical Care Adsorption Solutions Product Portfolio Table 61. Jafron Biomedical Recent Development Table 62. Guangzhou Kangsheng Biotechnology Company Information Table 63. Guangzhou Kangsheng Biotechnology Business Overview Table 64. Guangzhou Kangsheng Biotechnology Critical Care Adsorption Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Guangzhou Kangsheng Biotechnology Critical Care Adsorption Solutions Product Portfolio Table 66. Guangzhou Kangsheng Biotechnology Recent Development Table 67. Baihe Medical Company Information Table 68. Baihe Medical Business Overview Table 69. Baihe Medical Critical Care Adsorption Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Baihe Medical Critical Care Adsorption Solutions Product Portfolio Table 71. Baihe Medical Recent Development Table 72. Asahi Kasei Corporation Company Information Table 73. Asahi Kasei Corporation Business Overview Table 74. Asahi Kasei Corporation Critical Care Adsorption Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Asahi Kasei Corporation Critical Care Adsorption Solutions Product Portfolio Table 76. Asahi Kasei Corporation Recent Development Table 77. Toray Medical Company Information Table 78. Toray Medical Business Overview Table 79. Toray Medical Critical Care Adsorption Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Toray Medical Critical Care Adsorption Solutions Product Portfolio Table 81. Toray Medical Recent Development Table 82. Kaneka Medix Corporation Company Information Table 83. Kaneka Medix Corporation Business Overview Table 84. Kaneka Medix Corporation Critical Care Adsorption Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Kaneka Medix Corporation Critical Care Adsorption Solutions Product Portfolio Table 86. Kaneka Medix Corporation Recent Development Table 87. Research Programs/Design for This Report Table 88. Authors List of This Report Table 89. Secondary Sources Table 90. Primary Sources List of Figures Figure 1. Critical Care Adsorption Solutions Product Image Figure 2. Global Critical Care Adsorption Solutions Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Critical Care Adsorption Solutions Market Size (2021-2032) & (US$ Million) Figure 4. Global Critical Care Adsorption Solutions Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Immunoadsorption Image Figure 8. Lipid Adsorption Image Figure 9. Others Image Figure 10. Global Critical Care Adsorption Solutions Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Critical Care Adsorption Solutions Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Critical Care Adsorption Solutions Sales Value Share by Type (2021-2032) Figure 13. Cardiac Surgery Department Image Figure 14. Sepsis Image Figure 15. Burn Image Figure 16. Pancreatitis Image Figure 17. Others Image Figure 18. Global Critical Care Adsorption Solutions Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Critical Care Adsorption Solutions Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Critical Care Adsorption Solutions Sales Value Share by Application (2021-2032) Figure 21. Global Critical Care Adsorption Solutions Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Critical Care Adsorption Solutions Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Critical Care Adsorption Solutions Sales Value (2021-2032) & (US$ Million) Figure 24. North America Critical Care Adsorption Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Critical Care Adsorption Solutions Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Critical Care Adsorption Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Critical Care Adsorption Solutions Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Critical Care Adsorption Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Critical Care Adsorption Solutions Sales Value (2021-2032) & (US$ Million) Figure 30. South America Critical Care Adsorption Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Critical Care Adsorption Solutions Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Critical Care Adsorption Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Critical Care Adsorption Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Critical Care Adsorption Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Critical Care Adsorption Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Critical Care Adsorption Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Critical Care Adsorption Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Critical Care Adsorption Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Critical Care Adsorption Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Critical Care Adsorption Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Critical Care Adsorption Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Critical Care Adsorption Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Critical Care Adsorption Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Critical Care Adsorption Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Critical Care Adsorption Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Critical Care Adsorption Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Critical Care Adsorption Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Critical Care Adsorption Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Critical Care Adsorption Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Critical Care Adsorption Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Critical Care Adsorption Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Critical Care Adsorption Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Critical Care Adsorption Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Critical Care Adsorption Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Critical Care Adsorption Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Critical Care Adsorption Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Critical Care Adsorption Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Critical Care Adsorption Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Critical Care Adsorption Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Critical Care Adsorption Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Critical Care Adsorption Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Critical Care Adsorption Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Critical Care Adsorption Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Critical Care Adsorption Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Critical Care Adsorption Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Critical Care Adsorption Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Critical Care Adsorption Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Critical Care Adsorption Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Critical Care Adsorption Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Critical Care Adsorption Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Critical Care Adsorption Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Critical Care Adsorption Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Critical Care Adsorption Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Critical Care Adsorption Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Critical Care Adsorption Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Critical Care Adsorption Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Critical Care Adsorption Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Critical Care Adsorption Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Critical Care Adsorption Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Critical Care Adsorption Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Critical Care Adsorption Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Critical Care Adsorption Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Critical Care Adsorption Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Critical Care Adsorption Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Critical Care Adsorption Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Critical Care Adsorption Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Critical Care Adsorption Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Critical Care Adsorption Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Critical Care Adsorption Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Critical Care Adsorption Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Critical Care Adsorption Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Critical Care Adsorption Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Critical Care Adsorption Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Critical Care Adsorption Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Critical Care Adsorption Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Critical Care Adsorption Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Critical Care Adsorption Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Critical Care Adsorption Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Critical Care Adsorption Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Critical Care Adsorption Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Critical Care Adsorption Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Critical Care Adsorption Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Critical Care Adsorption Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Critical Care Adsorption Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Critical Care Adsorption Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Critical Care Adsorption Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Critical Care Adsorption Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Critical Care Adsorption Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Critical Care Adsorption Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Critical Care Adsorption Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Critical Care Adsorption Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Critical Care Adsorption Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Critical Care Adsorption Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Critical Care Adsorption Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Critical Care Adsorption Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Critical Care Adsorption Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Immunoadsorption
  • Lipid Adsorption
  • Others
Applications
  • Cardiac Surgery Department
  • Sepsis
  • Burn
  • Pancreatitis
  • Others
Companies covered
  • Aier
  • Biosun Corporation
  • Baxter
  • Jafron Biomedical
  • Guangzhou Kangsheng Biotechnology
  • Baihe Medical
  • Asahi Kasei Corporation
  • Toray Medical
  • Kaneka Medix Corporation

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Critical Care Adsorption Solutions Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Critical Care Adsorption Solutions Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Critical Care Adsorption Solutions Market Dynamics
  1. 2.1 Critical Care Adsorption Solutions Industry Trends
  2. 2.2 Critical Care Adsorption Solutions Industry Drivers
  3. 2.3 Critical Care Adsorption Solutions Industry Opportunities and Challenges
  4. 2.4 Critical Care Adsorption Solutions Industry Restraints
3 Critical Care Adsorption Solutions Market by Company
  1. 3.1 Global Critical Care Adsorption Solutions Company Revenue Ranking in 2025
  2. 3.2 Global Critical Care Adsorption Solutions Revenue by Company (2021-2026)
  3. 3.3 Global Critical Care Adsorption Solutions Company Ranking (2024-2026)
  4. 3.4 Global Critical Care Adsorption Solutions Company Manufacturing Base and Headquarters
  5. 3.5 Global Critical Care Adsorption Solutions Company Product Type and Application
  6. 3.6 Global Critical Care Adsorption Solutions Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Critical Care Adsorption Solutions Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Critical Care Adsorption Solutions Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Critical Care Adsorption Solutions Market by Type
  1. 4.1 Critical Care Adsorption Solutions Type Introduction
  2. 4.1.1 Immunoadsorption
  3. 4.1.2 Lipid Adsorption
  4. 4.1.3 Others
  5. 4.2 Global Critical Care Adsorption Solutions Sales Value by Type
  6. 4.2.1 Global Critical Care Adsorption Solutions Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Critical Care Adsorption Solutions Sales Value by Type (2021-2032)
  8. 4.2.3 Global Critical Care Adsorption Solutions Sales Value Share by Type (2021-2032)
5 Critical Care Adsorption Solutions Market by Application
  1. 5.1 Critical Care Adsorption Solutions Application Introduction
  2. 5.1.1 Cardiac Surgery Department
  3. 5.1.2 Sepsis
  4. 5.1.3 Burn
  5. 5.1.4 Pancreatitis
  6. 5.1.5 Others
  7. 5.2 Global Critical Care Adsorption Solutions Sales Value by Application
  8. 5.2.1 Global Critical Care Adsorption Solutions Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Critical Care Adsorption Solutions Sales Value by Application (2021-2032)
  10. 5.2.3 Global Critical Care Adsorption Solutions Sales Value Share by Application (2021-2032)
6 Critical Care Adsorption Solutions Regional Value Analysis
  1. 6.1 Global Critical Care Adsorption Solutions Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Critical Care Adsorption Solutions Sales Value by Region (2021-2032)
  3. 6.2.1 Global Critical Care Adsorption Solutions Sales Value by Region: 2021-2026
  4. 6.2.2 Global Critical Care Adsorption Solutions Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Critical Care Adsorption Solutions Sales Value (2021-2032)
  7. 6.3.2 North America Critical Care Adsorption Solutions Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Critical Care Adsorption Solutions Sales Value (2021-2032)
  10. 6.4.2 Europe Critical Care Adsorption Solutions Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Critical Care Adsorption Solutions Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Critical Care Adsorption Solutions Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Critical Care Adsorption Solutions Sales Value (2021-2032)
  16. 6.6.2 South America Critical Care Adsorption Solutions Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Critical Care Adsorption Solutions Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Critical Care Adsorption Solutions Sales Value Share by Country, 2025 VS 2032
7 Critical Care Adsorption Solutions Country-level Value Analysis
  1. 7.1 Global Critical Care Adsorption Solutions Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Critical Care Adsorption Solutions Sales Value by Country (2021-2032)
  3. 7.2.1 Global Critical Care Adsorption Solutions Sales Value by Country (2021-2026)
  4. 7.2.2 Global Critical Care Adsorption Solutions Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Critical Care Adsorption Solutions Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Critical Care Adsorption Solutions Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Critical Care Adsorption Solutions Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Critical Care Adsorption Solutions Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Critical Care Adsorption Solutions Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Critical Care Adsorption Solutions Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Critical Care Adsorption Solutions Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Critical Care Adsorption Solutions Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Critical Care Adsorption Solutions Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Critical Care Adsorption Solutions Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Critical Care Adsorption Solutions Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Critical Care Adsorption Solutions Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Critical Care Adsorption Solutions Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Critical Care Adsorption Solutions Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Critical Care Adsorption Solutions Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Critical Care Adsorption Solutions Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Critical Care Adsorption Solutions Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Critical Care Adsorption Solutions Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Critical Care Adsorption Solutions Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Critical Care Adsorption Solutions Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Critical Care Adsorption Solutions Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Critical Care Adsorption Solutions Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Critical Care Adsorption Solutions Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Critical Care Adsorption Solutions Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Critical Care Adsorption Solutions Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Critical Care Adsorption Solutions Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Critical Care Adsorption Solutions Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Critical Care Adsorption Solutions Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Critical Care Adsorption Solutions Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Critical Care Adsorption Solutions Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Critical Care Adsorption Solutions Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Critical Care Adsorption Solutions Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Critical Care Adsorption Solutions Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Critical Care Adsorption Solutions Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Critical Care Adsorption Solutions Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Critical Care Adsorption Solutions Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Critical Care Adsorption Solutions Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Critical Care Adsorption Solutions Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Critical Care Adsorption Solutions Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Critical Care Adsorption Solutions Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Critical Care Adsorption Solutions Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Critical Care Adsorption Solutions Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Critical Care Adsorption Solutions Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Critical Care Adsorption Solutions Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Critical Care Adsorption Solutions Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Critical Care Adsorption Solutions Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Critical Care Adsorption Solutions Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Critical Care Adsorption Solutions Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Critical Care Adsorption Solutions Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Critical Care Adsorption Solutions Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Critical Care Adsorption Solutions Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Critical Care Adsorption Solutions Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Critical Care Adsorption Solutions Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Critical Care Adsorption Solutions Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Critical Care Adsorption Solutions Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Critical Care Adsorption Solutions Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Critical Care Adsorption Solutions Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Critical Care Adsorption Solutions Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Critical Care Adsorption Solutions Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Critical Care Adsorption Solutions Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Critical Care Adsorption Solutions Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Critical Care Adsorption Solutions Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Critical Care Adsorption Solutions Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Critical Care Adsorption Solutions Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Critical Care Adsorption Solutions Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Critical Care Adsorption Solutions Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Critical Care Adsorption Solutions Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Critical Care Adsorption Solutions Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Critical Care Adsorption Solutions Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Critical Care Adsorption Solutions Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Critical Care Adsorption Solutions Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Critical Care Adsorption Solutions Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Critical Care Adsorption Solutions Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Critical Care Adsorption Solutions Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Critical Care Adsorption Solutions Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Critical Care Adsorption Solutions Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Critical Care Adsorption Solutions Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Critical Care Adsorption Solutions Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Critical Care Adsorption Solutions Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Critical Care Adsorption Solutions Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Critical Care Adsorption Solutions Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Critical Care Adsorption Solutions Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Critical Care Adsorption Solutions Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Critical Care Adsorption Solutions Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Aier
  2. 8.1.1 Aier Company Information
  3. 8.1.2 Aier Business Overview
  4. 8.1.3 Aier Critical Care Adsorption Solutions Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Aier Critical Care Adsorption Solutions Product Portfolio
  6. 8.1.5 Aier Recent Developments
  7. 8.2 Biosun Corporation
  8. 8.2.1 Biosun Corporation Company Information
  9. 8.2.2 Biosun Corporation Business Overview
  10. 8.2.3 Biosun Corporation Critical Care Adsorption Solutions Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Biosun Corporation Critical Care Adsorption Solutions Product Portfolio
  12. 8.2.5 Biosun Corporation Recent Developments
  13. 8.3 Baxter
  14. 8.3.1 Baxter Company Information
  15. 8.3.2 Baxter Business Overview
  16. 8.3.3 Baxter Critical Care Adsorption Solutions Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Baxter Critical Care Adsorption Solutions Product Portfolio
  18. 8.3.5 Baxter Recent Developments
  19. 8.4 Jafron Biomedical
  20. 8.4.1 Jafron Biomedical Company Information
  21. 8.4.2 Jafron Biomedical Business Overview
  22. 8.4.3 Jafron Biomedical Critical Care Adsorption Solutions Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Jafron Biomedical Critical Care Adsorption Solutions Product Portfolio
  24. 8.4.5 Jafron Biomedical Recent Developments
  25. 8.5 Guangzhou Kangsheng Biotechnology
  26. 8.5.1 Guangzhou Kangsheng Biotechnology Company Information
  27. 8.5.2 Guangzhou Kangsheng Biotechnology Business Overview
  28. 8.5.3 Guangzhou Kangsheng Biotechnology Critical Care Adsorption Solutions Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Guangzhou Kangsheng Biotechnology Critical Care Adsorption Solutions Product Portfolio
  30. 8.5.5 Guangzhou Kangsheng Biotechnology Recent Developments
  31. 8.6 Baihe Medical
  32. 8.6.1 Baihe Medical Company Information
  33. 8.6.2 Baihe Medical Business Overview
  34. 8.6.3 Baihe Medical Critical Care Adsorption Solutions Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Baihe Medical Critical Care Adsorption Solutions Product Portfolio
  36. 8.6.5 Baihe Medical Recent Developments
  37. 8.7 Asahi Kasei Corporation
  38. 8.7.1 Asahi Kasei Corporation Company Information
  39. 8.7.2 Asahi Kasei Corporation Business Overview
  40. 8.7.3 Asahi Kasei Corporation Critical Care Adsorption Solutions Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Asahi Kasei Corporation Critical Care Adsorption Solutions Product Portfolio
  42. 8.7.5 Asahi Kasei Corporation Recent Developments
  43. 8.8 Toray Medical
  44. 8.8.1 Toray Medical Company Information
  45. 8.8.2 Toray Medical Business Overview
  46. 8.8.3 Toray Medical Critical Care Adsorption Solutions Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Toray Medical Critical Care Adsorption Solutions Product Portfolio
  48. 8.8.5 Toray Medical Recent Developments
  49. 8.9 Kaneka Medix Corporation
  50. 8.9.1 Kaneka Medix Corporation Company Information
  51. 8.9.2 Kaneka Medix Corporation Business Overview
  52. 8.9.3 Kaneka Medix Corporation Critical Care Adsorption Solutions Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Kaneka Medix Corporation Critical Care Adsorption Solutions Product Portfolio
  54. 8.9.5 Kaneka Medix Corporation Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst